ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,93
-1,55%
Bitcoin
60 078,48
-5,89%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intercept Pharmaceuticals Inc (ICPT)

  7. Intercept Pharmaceuticals Inc (ICPT) Actualités

ICPT Intercept Pharmaceuticals Inc

19,00
0,00 (0,00%)
Après les heures de négociation
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Intercept Pharmaceuticals Inc ICPT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 19,00 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
19,00 19,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/2/202414:30GLOBEIntercept Announces FDA Acceptance of Supplemental New Drug..
20/11/202318:09EDGAR2Form 15-12G - Securities registration termination [Section..
15/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202320:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202314:00GLOBEIntercept Announces New Phase 2 Data Showing Significant..
10/11/202314:00GLOBEIntercept Announces New Findings from Long-term Extension of..
08/11/202322:44EDGAR2Form 8-K - Current report
08/11/202322:28EDGAR2Form POS AM - Post-Effective amendments for registration..
08/11/202322:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
08/11/202315:21EDGAR2Form 25-NSE - Notification filed by national security..
08/11/202315:13GLOBEAlfasigma completes acquisition of Intercept..
08/11/202313:50EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
08/11/202312:04EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
06/11/202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202314:10EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30/10/202313:49EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
26/10/202315:07EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
26/10/202314:54EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
18/10/202315:02EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
17/10/202323:12EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/10/202322:34EDGAR2Form SC 14D9 - Solicitation, recommendation statements
11/10/202322:16EDGAR2Form SC TO-T - Tender offer statement by Third Party
10/10/202317:10EDGAR2Form SC TO-C - Written communication relating to an issuer..
28/9/202323:17EDGAR2Form SC14D9C - Written communication relating to third party..
26/9/202323:06EDGAR2Form SC14D9C - Written communication relating to third party..
26/9/202318:43EDGAR2Form SC TO-C - Written communication relating to an issuer..
26/9/202314:28EDGAR2Form 8-K - Current report
26/9/202314:00GLOBEAlfasigma to Acquire Intercept Pharmaceuticals for $19.00..
25/9/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202314:30GLOBEIntercept Pharmaceuticals to Conduct Fireside Chats and..
03/8/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202313:05EDGAR2Form 8-K - Current report
02/8/202313:00GLOBEIntercept Pharmaceuticals Reports Second Quarter 2023..

Dernières Valeurs Consultées

NASDAQ
ICPT
Intercept Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés